Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 1.000 | |
| 1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
| 5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.496 | |
| 1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
| 1y91 | CT9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
| 3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.486 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.484 | |
| 2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.483 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.483 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.482 | |
| 1pxl | CK4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
| 4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.476 | |
| 2r3j | SCJ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
| 3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
| 1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
| 2vth | LZ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
| 1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
| 2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 1e1x | NW1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
| 1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 4nif | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
| 1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 3w55 | 1FM | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.457 | |
| 1ykr | 628 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 2b53 | D23 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.455 | |
| 4ek8 | 16K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 2r3i | SCF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
| 3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.451 | |
| 3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 1w8c | N69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.448 | |
| 2a4l | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.447 | |
| 1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.445 | |
| 1pye | PM1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.445 | |
| 2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
| 2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.443 | |
| 2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
| 1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3c50 | ADP | Rhodopsin kinase | / | 0.441 | |
| 3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
| 4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 1h1q | 2A6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.440 |